Advancing Personalized and Genomic Medicine: Exploring Information Needs and the Role of IT

Date: 

Friday, September 20, 2013

Time: 

10:00 AM to 12:30 PM

Venue: 

Bipartisan Policy Center

Address: 

1225 Eye St. NW
Suite 1000
Washington
DC
20005

Attached files:

Personalized and genomic medicine hold great promise to improving patient care, preventing disease, and reducing the cost of care, as well as decreasing the cost, size and duration of clinical trials. Significant advancements in these fields are enabling clinicians to tailor medical treatments and preventive strategies specifically to each patient.

The rapid digitization of the health care delivery system, along with increasingly empowered patients who can access and are interested in sharing their health information to promote improvements, helps bring personalized medicine within reach. However, several barriers continue to stand in the way of widespread adoption.

The Bipartisan Policy Center (BPC) brought together health care leaders to engage in a robust policy discussion regarding the information needs of personalized and genomic medicine, the role that health IT plays, the barriers that stand in the way of progress, and the policies needed to address those barriers.

Join the conversation on Twitter: @BPC_Bipartisan #PersonalizedMedicine


Opening Remarks:

Senator Bill Frist, M.D.
Former U.S. Senate Majority Leader
Co-Chair, BPC Health Project

Featuring:

Edward Abrahams, Ph.D.
President, Personalized Medicine Coalition

Alice Borrelli
Director of Global Healthcare Policy, Intel

Omri Gottesman, MD
Assistant Professor of General Internal Medicine, The Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai

Alice Leiter
Policy Counsel, Health Privacy Project, Center for Democracy and Technology

Leonard Lichtenfeld, MD
Deputy Chief Medical Officer, American Cancer Society

Andrew Litt, MD
Chief Medical Officer, Dell Healthcare & Life Sciences

Janet Marchibroda
Director, BPC Health Innovation Initiative

Josh F. Peterson, MD, MPH
Director of Health Information Technology Evaluation, Department of Biomedical Informatics and Medicine, Vanderbilt University Medical Center

Richard Schilsky, MD
Chief Medical Officer, American Society of Clinical Oncology

Jeffrey M. Trent, Ph.D.
President and Scientific Director, TGen

Mollie H. Ullman-Cullere, MS, MSE
Co-Chair Clinical Genomics Workgroup, Health Level Seven International (HL7)

BPC would like to acknowledge Dell Inc. for its support for widespread public access to and engagement in this event through the use of online tools and social media.